CompaniesNoscira

Noscira

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

3

As Collaborator

0

Total Enrollment

482

By Phase

PHASE2: 1NA: 1PHASE1/PHASE2: 1

By Status

COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
Today
NCT01049399
NCT01350362
Hover over trial bars to see details

Recent Trials

NCT01350362Lead Sponsor
Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients
PHASE2Completed
306 participants
Started: Apr 30, 2011 · Completed: Oct 31, 2012
NCT01049399Lead Sponsor
Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
NACompleted
146 participants
Started: Dec 31, 2009 · Completed: Nov 30, 2011
NCT00948259Lead Sponsor
Safety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s Disease
PHASE1/PHASE2Completed
30 participants
Started: Dec 31, 2008 · Completed: Nov 30, 2009